Broadfin Capital, LLC historic quarter change: USA Options, New
In put and call options, at their filed underlying value (listed in the US), over 13 quarters from 2013-06-30 to 2016-09-30, Broadfin Capital, LLC opened 22 positions, added to 8, reduced 7 and sold out of 18.
- Q3 2016: Stock XBI; Country of operation —; Class S&P BIOTECH · Put; Shares before 0.
- Q3 2016: Stock HRTX; Country of operation United States; Class COM · Call; Shares before 0.
- Q3 2016: Stock PCRX; Country of operation United States; Class COM · Call; Shares before 0.
- Q2 2016: Stock SPY; Country of operation —; Class TR UNIT · Put; Shares before 0.
Each consecutive pair of Form 13F-HR filings compared (SEC CIK 1511901), 13 quarters: Q3 2016 (2016-06-30 to 2016-09-30, filed 2016-11-14); Q2 2016 (2016-03-31 to 2016-06-30, filed 2016-08-15); Q1 2016 (2015-12-31 to 2016-03-31, filed 2016-05-16); Q4 2015 (2015-09-30 to 2015-12-31, filed 2016-02-16); Q3 2015 (2015-06-30 to 2015-09-30, filed 2015-11-16); Q2 2015 (2015-03-31 to 2015-06-30, filed 2015-08-14); Q1 2015 (2014-12-31 to 2015-03-31, filed 2015-05-15); Q4 2014 (2014-09-30 to 2014-12-31, filed 2015-02-17); Q3 2014 (2014-06-30 to 2014-09-30, filed 2014-11-14); Q2 2014 (2014-03-31 to 2014-06-30, filed 2014-08-14); Q1 2014 (2013-12-31 to 2014-03-31, filed 2014-05-15); Q4 2013 (2013-09-30 to 2013-12-31, filed 2014-02-28); Q3 2013 (2013-06-30 to 2013-09-30, filed 2013-11-14). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move. Only the filings held here are compared; the firm's 13F-HR filings go back to the quarter ended 2010-12-31.
| Quarter | Stock | Country of operation | Class | Shares before | Shares after | Share change | Value before | Value after | Value change | Filed |
|---|
| Q3 2016 | XBI
SPDR SERIES TRUST | | S&P BIOTECH · Put | 0 | 500,000 | +500,000 | $0 | $33,145,000 | +$33,145,000 | 2016-11-14 |
|---|
| Q3 2016 | HRTX
HERON THERAPEUTICS INC | United States | COM · Call | 0 | 300,000 | +300,000 | $0 | $5,169,000 | +$5,169,000 | 2016-11-14 |
|---|
| Q3 2016 | PCRX
PACIRA PHARMACEUTICALS INC | United States | COM · Call | 0 | 150,000 | +150,000 | $0 | $5,133,000 | +$5,133,000 | 2016-11-14 |
|---|
| Q2 2016 | SPY
SPDR S&P 500 ETF TR | | TR UNIT · Put | 0 | 550,000 | +550,000 | $0 | $115,211,000 | +$115,211,000 | 2016-08-15 |
|---|
| Q2 2016 | ENDO INTL PLC
CUSIP G30401106 | | SHS · Call | 0 | 200,000 | +200,000 | $0 | $3,118,000 | +$3,118,000 | 2016-08-15 |
|---|
| Q1 2016 | ANACOR PHARMACEUTICALS INC
CUSIP 032420101 | | COM · Call | 0 | 400,000 | +400,000 | $0 | $21,380,000 | +$21,380,000 | 2016-05-16 |
|---|
| Q1 2016 | NEVRO CORP
CUSIP 64157F103 | United States | COM · Call | 0 | 300,000 | +300,000 | $0 | $16,878,000 | +$16,878,000 | 2016-05-16 |
|---|
| Q4 2015 | VALEANT PHARMACEUTICALS INTL
CUSIP 91911K102 | | COM · Call | 0 | 100,000 | +100,000 | $0 | $10,165,000 | +$10,165,000 | 2016-02-16 |
|---|
| Q4 2015 | NOVADAQ TECHNOLOGIES INC
CUSIP 66987G102 | | COM · Call | 0 | 500,000 | +500,000 | $0 | $6,370,000 | +$6,370,000 | 2016-02-16 |
|---|
| Q4 2015 | AEGERION PHARMACEUTICALS INC
CUSIP 00767E102 | | COM · Call | 0 | 500,000 | +500,000 | $0 | $5,050,000 | +$5,050,000 | 2016-02-16 |
|---|
| Q3 2015 | HRTX
HERON THERAPEUTICS INC | United States | COM · Call | 0 | 500,000 | +500,000 | $0 | $12,200,000 | +$12,200,000 | 2015-11-16 |
|---|
| Q3 2015 | RETROPHIN INC
CUSIP 761299106 | | COM · Call | 0 | 500,000 | +500,000 | $0 | $10,130,000 | +$10,130,000 | 2015-11-16 |
|---|
| Q3 2015 | NEVRO CORP
CUSIP 64157F103 | United States | COM · Call | 0 | 200,000 | +200,000 | $0 | $9,278,000 | +$9,278,000 | 2015-11-16 |
|---|
| Q2 2015 | IWM
ISHARES TR | | RUSSELL 2000 ETF · Put | 0 | 1,750,000 | +1,750,000 | $0 | $218,505,000 | +$218,505,000 | 2015-08-14 |
|---|
| Q2 2015 | XBI
SPDR SERIES TRUST | | S&P BIOTECH · Put | 0 | 285,000 | +285,000 | $0 | $71,888,000 | +$71,888,000 | 2015-08-14 |
|---|
| Q2 2015 | BIODELIVERY SCIENCES INTL IN
CUSIP 09060J106 | | COM · Call | 0 | 750,000 | +750,000 | $0 | $5,970,000 | +$5,970,000 | 2015-08-14 |
|---|
| Q1 2015 | RETROPHIN INC
CUSIP 761299106 | | COM · Call | 0 | 500,000 | +500,000 | $0 | $11,198,000 | +$11,198,000 | 2015-05-15 |
|---|
| Q4 2014 | HORIZON PHARMA PLC
CUSIP G4617B105 | | SHS · Call | 0 | 300,000 | +300,000 | $0 | $3,867,000 | +$3,867,000 | 2015-02-17 |
|---|
| Q4 2014 | AEGERION PHARMACEUTICALS INC
CUSIP 00767E102 | | COM · Call | 0 | 150,000 | +150,000 | $0 | $3,141,000 | +$3,141,000 | 2015-02-17 |
|---|
| Q4 2014 | PROGENICS PHARMACEUTICALS IN
CUSIP 743187106 | | COM · Call | 0 | 200,000 | +200,000 | $0 | $1,512,000 | +$1,512,000 | 2015-02-17 |
|---|
| Q3 2014 | HORIZON PHARMA PLC
CUSIP G4617B105 | | COM · Call | 0 | 2,000 | +2,000 | $0 | $450,000 | +$450,000 | 2014-11-14 |
|---|
| Q2 2014 | INFIQ
INFINITY PHARMACEUTICALS INC | United States | COM · Call | 0 | 1,500 | +1,500 | $0 | $443,000 | +$443,000 | 2014-08-14 |
|---|
Similar Firms
| Firm Name | Country | 13F Value | Holdings |
|---|
| Not available yet |